Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief Medical Officer
European Hematology Association (EHA) oral presentation to report 67% hematological improvement, durable…
Dstillerys Melinda Han Williams Named to ADWEEKs AI Power 50
Dstillery Chief Data Scientist recognized for AI innovation March 09, 2026 12:52…
